Zomedica (ZOMDF) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Zomedica Corp   (NONE: ZOMDF)

Zomedica Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZOMDF Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q1 MRQ) 64.64 % 70.91 % 67.38 % 46.15 %
Gross Margin (Q1 TTM) 68.22 % 71.7 % 67.8 % 46.36 %
Gross Profit Margin 5 Yr. Avg. - 67.81 % 65.55 % 48.95 %
EBITDA Margin (Q1 MRQ) -30.69 % 21.48 % 18.44 % 20.46 %
EBITDA Margin (Q1 TTM) -47.37 % 25.18 % 20.78 % 20.1 %
EBITDA Margin 5 Yr. Avg. - 47.09 % 31.38 % 23.39 %
Operating Margin (Q1 MRQ) -57.76 % 17.3 % 16.52 % 16.05 %
Operating Margin (Q1 TTM) -75.85 % 20.35 % 17.83 % 16.34 %
Operating Margin 5 Yr. Avg. - 15.37 % 14.33 % 19.26 %
Pre-Tax Profit Margin (Q1 MRQ) -52.98 % 13.68 % 10.72 % 13.96 %
Pre-Tax Profit Margin (Q1 TTM) -68.25 % 16.7 % 12.68 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 12.98 % 10.37 % 13.52 %
Net Margin (Q1 MRQ) -53.44 % 10.12 % 8.02 % 11.42 %
Net Margin (Q1 TTM) -67.7 % 13.16 % 9.86 % 10.76 %
Net Margin 5 Yr. Avg. - 5.79 % 6.08 % 10.8 %



Business Segment Profit Margin
 
Capital
  Explore Capital Segment  -
Consumables
  Explore Consumables Segment  -
Engineering
  Explore Engineering Segment  -
Other
  Explore Other Segment  -
Diagnostics
  Explore Diagnostics Segment  36.34 %
Diagnostics Capital
  Explore Diagnostics Capital Segment  -
Diagnostics Consumables
  Explore Diagnostics Consumables Segment  -
Therapeutic Devices
  Explore Therapeutic Devices Segment  69.54 %
Therapeutic Devices Capital
  Explore Therapeutic Devices Capital Segment  -
Therapeutic Devices Consumables
  Explore Therapeutic Devices Consumables Segment  -
Therapeutic Devices Other
  Explore Therapeutic Devices Other Segment  -
Development Services
  Explore Development Services Segment  53.93 %
Development Services Capital
  Explore Development Services Capital Segment  -
Development Services Consumables
  Explore Development Services Consumables Segment  -
Development Services Engineering
  Explore Development Services Engineering Segment  -
Development Services Other
  Explore Development Services Other Segment  -
US
  Explore US Segment  -
Foreign countries
  Explore Foreign countries Segment  -
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q1 MRQ) -68.01 % -0.01 % 0.22 % 1.39 %
Free Cash Flow Margin (Q1 TTM) -67.16 % 17.26 % 13.83 % 9.09 %
Free Cash Flow Margin 5 Yr. Avg. - 19.28 % 14.86 % 15.58 %
Net Cash Flow Margin (Q1 MRQ) 4.3 % 0.02 % -0.02 % 0.13 %
Net Cash Flow Margin (Q1 TTM) 1.6 % -0.67 % 0.15 % 1.85 %
Net Cash Flow Margin 5 Yr. Avg. - 4.38 % 3.16 % 6.44 %
Effective Tax Rate (Q1 MRQ) -0.87 % 25.92 % 25.04 % 18.8 %
Effective Tax Rate (Q1 TTM) 0.63 % 21.21 % 23 % 19.44 %
Effective Tax Rate 5 Yr. Avg. - 15.08 % 20.51 % 19.76 %
Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.